783 related articles for article (PubMed ID: 26466614)
1. Utility of TWEAK to assess neuropsychiatric disease activity in systemic lupus erhytematosus.
Fragoso-Loyo H; Atisha-Fregoso Y; Nuñez-Alvarez CA; Llorente L
Lupus; 2016 Apr; 25(4):364-9. PubMed ID: 26466614
[TBL] [Abstract][Full Text] [Related]
2. Utility of interferon-α as a biomarker in central neuropsychiatric involvement in systemic lupus erythematosus.
Fragoso-Loyo H; Atisha-Fregoso Y; Núñez-Alvarez CA; Llorente L; Sánchez-Guerrero J
J Rheumatol; 2012 Mar; 39(3):504-9. PubMed ID: 22247358
[TBL] [Abstract][Full Text] [Related]
3. Serum and cerebrospinal fluid autoantibodies in patients with neuropsychiatric lupus erythematosus. Implications for diagnosis and pathogenesis.
Fragoso-Loyo H; Cabiedes J; Orozco-Narváez A; Dávila-Maldonado L; Atisha-Fregoso Y; Diamond B; Llorente L; Sánchez-Guerrero J
PLoS One; 2008 Oct; 3(10):e3347. PubMed ID: 18836530
[TBL] [Abstract][Full Text] [Related]
4. Interleukin-6 and chemokines in the neuropsychiatric manifestations of systemic lupus erythematosus.
Fragoso-Loyo H; Richaud-Patin Y; Orozco-Narváez A; Dávila-Maldonado L; Atisha-Fregoso Y; Llorente L; Sánchez-Guerrero J
Arthritis Rheum; 2007 Apr; 56(4):1242-50. PubMed ID: 17393453
[TBL] [Abstract][Full Text] [Related]
5. Is serum TWEAK a useful biomarker of neuropsychiatric systemic lupus erythematosus?
Balajkova V; Olejarova M; Moravcova R; Kozelek P; Posmurova M; Hulejova H; Senolt L
Physiol Res; 2020 Apr; 69(2):339-346. PubMed ID: 32199014
[TBL] [Abstract][Full Text] [Related]
6. The heterogeneity of neuropsychiatric systemic lupus erythematosus is reflected in lack of association with cerebrospinal fluid cytokine profiles.
Jönsen A; Bengtsson AA; Nived O; Ryberg B; Truedsson L; Rönnblom L; Alm GV; Sturfelt G
Lupus; 2003; 12(11):846-50. PubMed ID: 14667101
[TBL] [Abstract][Full Text] [Related]
7. Serum neuron specific enolase - a novel indicator for neuropsychiatric systemic lupus erythematosus?
Hawro T; Bogucki A; Krupińska-Kun M; Maurer M; Woźniacka A
Lupus; 2015 Dec; 24(14):1492-7. PubMed ID: 26124236
[TBL] [Abstract][Full Text] [Related]
8. Raised intrathecal levels of APRIL and BAFF in patients with systemic lupus erythematosus: relationship to neuropsychiatric symptoms.
George-Chandy A; Trysberg E; Eriksson K
Arthritis Res Ther; 2008; 10(4):R97. PubMed ID: 18718031
[TBL] [Abstract][Full Text] [Related]
9. Elevated levels of soluble fractalkine in active systemic lupus erythematosus: potential involvement in neuropsychiatric manifestations.
Yajima N; Kasama T; Isozaki T; Odai T; Matsunawa M; Negishi M; Ide H; Kameoka Y; Hirohata S; Adachi M
Arthritis Rheum; 2005 Jun; 52(6):1670-5. PubMed ID: 15934075
[TBL] [Abstract][Full Text] [Related]
10. Lymphocytotoxic antibodies in systemic lupus erythematosus are associated with disease activity irrespective of the presence of neuropsychiatric manifestations.
Magalhães MB; da Silva LM; Voltarelli JC; Donadi EA; Louzada-Junior P
Scand J Rheumatol; 2007; 36(6):442-7. PubMed ID: 18092265
[TBL] [Abstract][Full Text] [Related]
11. Antiribosomal P protein antibodies in cerebrospinal fluid are associated with neuropsychiatric systemic lupus erythematosus.
Yoshio T; Hirata D; Onda K; Nara H; Minota S
J Rheumatol; 2005 Jan; 32(1):34-9. PubMed ID: 15630721
[TBL] [Abstract][Full Text] [Related]
12. IL-6, IL-8, IP-10, MCP-1 and G-CSF are significantly increased in cerebrospinal fluid but not in sera of patients with central neuropsychiatric lupus erythematosus.
Yoshio T; Okamoto H; Kurasawa K; Dei Y; Hirohata S; Minota S
Lupus; 2016 Aug; 25(9):997-1003. PubMed ID: 26846690
[TBL] [Abstract][Full Text] [Related]
13. Clinical significance of anti-DNA/N-methyl-D-aspartate receptor 2 antibodies in de novo and post-steroid cases with neuropsychiatric systemic lupus erythematosus.
Fujieda Y; Mader S; Jeganathan V; Arinuma Y; Shimizu Y; Kato M; Oku K; Minami A; Shimizu C; Yasuda S; Atsumi T
Int J Rheum Dis; 2019 Mar; 22(3):443-448. PubMed ID: 30358102
[TBL] [Abstract][Full Text] [Related]
14. Participation of the neutrophin brain-derived neurotrophic factor in neuropsychiatric systemic lupus erythematosus.
Tamashiro LF; Oliveira RD; Oliveira R; Frota ER; Donadi EA; Del-Ben CM; Teixeira AL; Louzada-Junior P
Rheumatology (Oxford); 2014 Dec; 53(12):2182-90. PubMed ID: 24942492
[TBL] [Abstract][Full Text] [Related]
15. Neuropsychiatric manifestations in pediatric systemic lupus erythematosus: a 20-year study.
Yu HH; Lee JH; Wang LC; Yang YH; Chiang BL
Lupus; 2006; 15(10):651-7. PubMed ID: 17120591
[TBL] [Abstract][Full Text] [Related]
16. Relationship between elevated cerebrospinal fluid levels of plasminogen activator inhibitor 1 and neuronal destruction in patients with neuropsychiatric systemic lupus erythematosus.
Kwieciński J; Kłak M; Trysberg E; Blennow K; Tarkowski A; Jin T
Arthritis Rheum; 2009 Jul; 60(7):2094-101. PubMed ID: 19565516
[TBL] [Abstract][Full Text] [Related]
17. [Clinical significance of neuro-reactive autoantibodies in neuro-psychiatric systemic lupus erythematosus].
Lu XY; Ye S; Wang Y; Guo L; Chen XX; Fan W; Wang XD; Gu YY; Bao CD; Liu Q
Zhonghua Yi Xue Za Zhi; 2006 Sep; 86(35):2462-6. PubMed ID: 17156673
[TBL] [Abstract][Full Text] [Related]
18. Inflammatory profile in cerebrospinal fluid of patients with headache as a manifestation of neuropsychiatric systemic lupus erythematosus.
Fragoso-Loyo H; Atisha-Fregoso Y; Llorente L; Sánchez-Guerrero J
Rheumatology (Oxford); 2013 Dec; 52(12):2218-22. PubMed ID: 24026247
[TBL] [Abstract][Full Text] [Related]
19. Autoantibody profiling on human proteome microarray for biomarker discovery in cerebrospinal fluid and sera of neuropsychiatric lupus.
Hu C; Huang W; Chen H; Song G; Li P; Shan Q; Zhang X; Zhang F; Zhu H; Wu L; Li Y
PLoS One; 2015; 10(5):e0126643. PubMed ID: 25954975
[TBL] [Abstract][Full Text] [Related]
20. Clinical features of central nervous system infections and experience in differential diagnosis from neuropsychiatric lupus erythematosus in a cohort of 8491 patients with systemic lupus erythematosus.
Jiang M; Shi X; Gao X; Niu J; Hu X; Zhao L; Zhang X
Arthritis Res Ther; 2019 Aug; 21(1):189. PubMed ID: 31426834
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
